Clinical and experimental neuroprotection in neurodegenerative diseases is a therapeutic option for the future of amyotrophic lateral sclerosis (ALS). Preface.

A. C. Ludolph; V. E. Drory

Clinical and experimental neuroprotection in neurodegenerative diseases is a therapeutic option for the future of amyotrophic lateral sclerosis (ALS). Preface.

A. C. Ludolph^*, V. E. Drory

^*Corresponding author for this work

Neurology

Research output: Contribution to journal › Editorial

1 Scopus citations

Original language	English
Pages (from-to)	VI/1
Journal	Journal of Neurology
Volume	247 Suppl 6
State	Published - Dec 2000

Cite this

@article{95ab2cbb06684bf4a52b6ad7fb194172,

title = "Clinical and experimental neuroprotection in neurodegenerative diseases is a therapeutic option for the future of amyotrophic lateral sclerosis (ALS). Preface.",

author = "Ludolph, {A. C.} and Drory, {V. E.}",

year = "2000",

month = dec,

language = "אנגלית",

volume = "247 Suppl 6",

pages = "VI/1",

journal = "Journal of Neurology",

issn = "0340-5354",

publisher = "D. Steinkopff-Verlag",

}

TY - JOUR

T1 - Clinical and experimental neuroprotection in neurodegenerative diseases is a therapeutic option for the future of amyotrophic lateral sclerosis (ALS). Preface.

AU - Ludolph, A. C.

AU - Drory, V. E.

PY - 2000/12

Y1 - 2000/12

UR - http://www.scopus.com/inward/record.url?scp=70349323309&partnerID=8YFLogxK

M3 - ???researchoutput.researchoutputtypes.contributiontojournal.editorial???

C2 - 19714407

AN - SCOPUS:70349323309

SN - 0340-5354

VL - 247 Suppl 6

SP - VI/1

JO - Journal of Neurology

JF - Journal of Neurology

ER -

Clinical and experimental neuroprotection in neurodegenerative diseases is a therapeutic option for the future of amyotrophic lateral sclerosis (ALS). Preface.

Other files and links

Cite this